Gossamer Bio Inc (GOSS)
0.8793
-0.01
(-0.79%)
USD |
NASDAQ |
Nov 05, 16:00
0.8793
0.00 (0.00%)
After-Hours: 18:55
Gossamer Bio Enterprise Value: 43.07M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 43.07M |
| November 01, 2024 | 40.22M |
| October 31, 2024 | 41.19M |
| October 30, 2024 | 45.26M |
| October 29, 2024 | 49.40M |
| October 28, 2024 | 50.01M |
| October 25, 2024 | 55.47M |
| October 24, 2024 | 46.17M |
| October 23, 2024 | 43.68M |
| October 22, 2024 | 43.79M |
| October 21, 2024 | 50.92M |
| October 18, 2024 | 60.19M |
| October 17, 2024 | 60.31M |
| October 16, 2024 | 62.00M |
| October 15, 2024 | 61.55M |
| October 14, 2024 | 55.62M |
| October 11, 2024 | 60.87M |
| October 10, 2024 | 65.10M |
| October 09, 2024 | 71.05M |
| October 08, 2024 | 73.31M |
| October 07, 2024 | 80.10M |
| October 04, 2024 | 84.63M |
| October 03, 2024 | 71.05M |
| October 02, 2024 | 80.10M |
| October 01, 2024 | 80.10M |
| Date | Value |
|---|---|
| September 30, 2024 | 65.71M |
| September 27, 2024 | 59.74M |
| September 26, 2024 | 57.93M |
| September 25, 2024 | 64.94M |
| September 24, 2024 | 67.41M |
| September 23, 2024 | 68.79M |
| September 20, 2024 | 80.10M |
| September 19, 2024 | 59.70M |
| September 18, 2024 | 48.68M |
| September 17, 2024 | 45.87M |
| September 16, 2024 | 48.43M |
| September 13, 2024 | 51.01M |
| September 12, 2024 | 41.64M |
| September 11, 2024 | 43.93M |
| September 10, 2024 | 50.81M |
| September 09, 2024 | 52.95M |
| September 06, 2024 | 48.43M |
| September 05, 2024 | 59.90M |
| September 04, 2024 | 36.85M |
| September 03, 2024 | 38.77M |
| August 30, 2024 | 41.15M |
| August 29, 2024 | 37.32M |
| August 28, 2024 | 41.98M |
| August 27, 2024 | 49.29M |
| August 26, 2024 | 51.55M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.462M
Minimum
Oct 24 2023
1.400B
Maximum
Aug 24 2022
418.59M
Average
382.32M
Median
Dec 11 2020
Enterprise Value Benchmarks
| Bioxytran Inc | 8.730M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 49.23M |
| Revenue (Quarterly) | 95.84M |
| Total Expenses (Quarterly) | 43.76M |
| EPS Diluted (Quarterly) | 0.22 |
| Profit Margin (Quarterly) | 51.37% |
| Earnings Yield | -37.53% |